Anteotech Ltd · ASX:ADO
Anteotech — Anteo Diagnostics — Shareholder Meeting (October 2011)
7 slides from Anteotech's shareholder meeting presentation, Oct 24, 2011
Slide 1: FY2011 Annual General Meeting
For personal use only Anteo Diagnostics (ASX:ADO) FY2011 Annual General Meeting (AGM) Better Binding - Faster Dr. Geoff Cumming - CEO Monday 24 October, 2011
Slide 2: CEO's Address – Dr Geoff Cumming
CEO’s Address – Dr Geoff Cumming For personal use only • A year of significant progress for Anteo • An experienced and capable Board of Directors now in place – Appointments of Ms Sandra Anderson & Mr Mark Bouris • Highly experienced management and technical team – Dr Joe Maeji, Dr Nevin Abernethy,
Slide 3: FY2011 Highlights
CEO’s Address - Dr Geoff Cumming FY2011 Highlights For personal use only • July 2010 – ADO announces agreed terms with Merck Chimie SAS • February 2011 – ADO raises $5.1m from existing shareholders through option conversion • February 2011 – Bangs Laboratories launches second product using Mix&Go™ •
Slide 4: A snapshot of the Mix&Go Technology
CEO’s Address - Dr. Geoff Cumming A snapshot of the Mix&Go™ Technology For personal use only • ADO has developed Mix&Go™ – a molecular ‘glue’ that significantly improves pathology tests • Mix&Go™ is a novel ‘glue’ - like a two sided velcro • Mix&Go™ technology results in earlier detection of disease
Slide 5: Anteo's Short Term Value Drivers
CEO’s Address - Dr Geoff Cumming Anteo’s Short Term Value Drivers For personal use only In Vitro Diagnostics (IVD) Market • Global leading IVD companies currently undertaking real time stability testing and associated studies for Mix&Go™ • The IVD market is valued at $10 billion per annum Research &
Slide 6: A strong start to FY2012
A strong start to FY2012 For personal use only • Appointment of highly experienced Non-Executive Chairman • Recently hired three new Scientists • Continued growth of pipeline of opportunities • Anteo is in excellent shape and well positioned for the year ahead
Slide 7: Shareholder Questions
Shareholder Questions For personal use only Dr. Geoff Cumming Chief Executive Officer Anteo Diagnostics Limited Tel: +61 2 8823 3110
Anteo Diagnostics — Shareholder Meeting (October 2011) on 6ix